Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial (vol 329, pg 296, 2023)

被引：1
|
作者：
Mccarthy, M. W.
Naggie, S.
Boulware, D. R.
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 330卷 / 16期
关键词：
D O I：
10.1001/jama.2023.20908
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1589 / 1589
页数：1
相关论文
共 50 条
  • [41] Amantadine in unvaccinated patients with early, mild to moderate COVID-19: A randomized, placebo-controlled, double-blind trial
    Rejdak, Konrad
    Fiedor, Piotr
    Bonek, Robert
    Lukasiak, Jacek
    Chelstowski, Waldemar
    Kiciak, Slawomir
    Dabrowski, Piotr
    Gala-Bladzinska, Agnieszka
    Dec, Mateusz
    Papuc, Ewa
    Zasybska, Adriana
    Kaczor, Marcin
    Grieb, Pawel
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (01)
  • [42] Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19 A Phase 2 Randomized Clinical Trial
    Cafardi, John
    Miller, Carole
    Terebelo, Howard
    Tewell, Chad
    Benzaquen, Sadia
    Park, David
    Egan, Pamela
    Lebovic, Daniel
    Pettit, Kristen
    Whitman, Eric
    Tremblay, Douglas
    Feld, Jonathan
    Buckley, Sarah
    Roman-Torres, Karisse
    Smith, Jennifer
    Craig, Adam
    Mascarenhas, John
    JAMA NETWORK OPEN, 2022, 5 (12) : e2242918
  • [43] Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial (vol 78, pg 951, 2021)
    Deligiannidis, K. M.
    Meltzer-Brody, S.
    Gunduz-Bruce, H.
    JAMA PSYCHIATRY, 2022, 79 (07) : 740 - 740
  • [44] Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19 A Randomized Clinical Trial
    Caricchio, Roberto
    Abbate, Antonio
    Gordeev, Ivan
    Meng, Jamie
    Hsue, Priscilla Y.
    Neogi, Tuhina
    Arduino, Roberto
    Fomina, Daria
    Bogdanov, Roman
    Stepanenko, Tatiana
    Ruiz-Seco, Pilar
    Gonzalez-Garcia, Andres
    Chen, Yu
    Li, Yuhan
    Whelan, Sarah
    Noviello, Stephanie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (03): : 230 - 239
  • [45] Effect of Ammonium Chloride in addition to standard of care in outpatients and hospitalized COVID-19 patients: A randomized clinical trial
    Siami, Zeinab
    Aghajanian, Sepehr
    Mansouri, Somayeh
    Mokhames, Zakiye
    Pakzad, Reza
    Kabir, Kourosh
    Norouzi, Mehdi
    Soleimani, Alireza
    Yaghoobi, Mojtaba Hedayat
    Shadabi, Shahrzad
    Tajbakhsh, Ramin
    Kheirabad, Ali Kargar
    Mozhgani, Sayed-Hamidreza
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 108 : 306 - 308
  • [46] Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
    Anan Manomaipiboon
    Kittisak Pholtawornkulchai
    Sujaree Poopipatpab
    Swangjit Suraamornkul
    Jakravoot Maneerit
    Wiroj Ruksakul
    Uraporn Phumisantiphong
    Thananda Trakarnvanich
    Trials, 23
  • [47] Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
    Manomaipiboon, Anan
    Pholtawornkulchai, Kittisak
    Poopipatpab, Sujaree
    Suraamornkul, Swangjit
    Maneerit, Jakravoot
    Ruksakul, Wiroj
    Phumisantiphong, Uraporn
    Trakarnvanich, Thananda
    TRIALS, 2022, 23 (01)
  • [48] Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial
    Bruen, Charles
    Al-Saadi, Mukhtar
    Michelson, Edward A.
    Tanios, Maged
    Mendoza-Ayala, Raul
    Miller, Joseph
    Zhang, Jeffrey
    Stauderman, Kenneth
    Hebbar, Sudarshan
    Hou, Peter C.
    CRITICAL CARE, 2022, 26 (01)
  • [49] Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial
    Charles Bruen
    Mukhtar Al-Saadi
    Edward A. Michelson
    Maged Tanios
    Raul Mendoza-Ayala
    Joseph Miller
    Jeffrey Zhang
    Kenneth Stauderman
    Sudarshan Hebbar
    Peter C. Hou
    Critical Care, 26
  • [50] Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial (vol 10, 1139046, 2023)
    FRONTIERS IN MEDICINE, 2023, 10
12345